Who has invested in GenEdit?

DCVC Bio, Eli Lilly are named among the investors backing GenEdit.

GenEdit Funding: $59M Raised, Series A (2021)

GenEdit funding overview

GenEdit is based in South San Francisco. GenEdit has raised $59M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2021. The round record for GenEdit runs through 2021; nothing later has been disclosed. Investors on record include DCVC Bio, Eli Lilly. 2 distinct backers are named across the disclosed rounds.

GenEdit at a glance

Total raised: $59M
Latest round: Series A
Latest round date: September 2021
Headquarters: South San Francisco
Notable investors: DCVC Bio, Eli Lilly

Frequently asked about GenEdit funding

How much has GenEdit raised?: GenEdit has raised $59M in total disclosed funding across the rounds on record.
Who has invested in GenEdit?: DCVC Bio, Eli Lilly are named among the investors backing GenEdit.
What was the latest GenEdit funding round?: The most recent disclosed round is a Series A, announced in September 2021.
Where is GenEdit based?: GenEdit is based in South San Francisco.
When did GenEdit last raise?: The last disclosed GenEdit round closed in September 2021 at Series A.

Every GenEdit figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in South San Francisco at a similar stage.

GenEdit Funding: $59M Raised, Series A (2021)

GenEdit funding overview

GenEdit at a glance

Frequently asked about GenEdit funding

Companies related to GenEdit (34)

Browse related funding lists (5)